Vaginal swabs are the optimal specimen for detection of genital chlamydia trachomatis or neisseria gonorrhoeae using the cobas 4800 CT/NG test

Sexually Transmitted Diseases

Volumn 40, Issue 3, 2013, Pages 247-250

  Van Der Pol, Barbara ^a,b   Taylor, Stephanie N ^c   Liesenfeld, Oliver ^d   Williams, James A ^b   Hook, Edward W ^e,f  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d ROCHE MOLECULAR SYSTEMS   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f Jefferson County Health Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL PRACTICE; CYTOLOGY; ENDOCERVICAL SWAB; FAMILY PLANNING; GONORRHEA; HUMAN; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION; PAPANICOLAOU TEST; SENSITIVITY AND SPECIFICITY; URINALYSIS; VAGINA SMEAR; VAGINA SWAB;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PATIENT PREFERENCE; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; URINE; VAGINA; VAGINAL SMEARS;

EID: 84874072123     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3182717833     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. Morb Mortal Wkly Rep 2010; 59(RR-12):1-112.
2. Centers for Disease Control and Prevention. Chlamydia screening percentages reported by commercial and medicaid plans by state and year. 2010; http://www.cdc.gov/std/chlamydia/female-enrollees-00-08.htm. Accessed November 24, 2010.
3. Centers for Disease Control and Prevention. Laboaratory diagnostic testing for Chlamydia trachomatis and Neisseria gonorrhoeae. 2009; http://www.aphl.org/aphlprograms/infectious/std/documents/ ctgclabguidelinesmeetingreport.pdf. Accessed 29 Oct 2011.
4. Hook EI, Smith K, Mullen C, et al. Diagnosis of genitourinary Chlamydia trachomatis infections by using ligase chain reaction on patient-obtained vaginal swabs. J Clin Microbiol 1997; 38: 2133-2135.
5. Hook EW III, Ching SF, Stephens J, et al. Diagnosis of Neisseria gonorrhoeae infections in women by using the ligase chain reaction on patient-obtained vaginal swabs. J Clin Microbiol 1997; 35: 2129-2132.
6. Blake DR, Maldeis N, Barnes MR, et al. Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transm Dis 2008; 35:649-655.
7. Hobbs MM, van der Pol B, Totten P, et al. From the NIH: Proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis 2008; 35:8-13.
8. Jones HE, Altini L, de KA, et al. Home-based versus clinic-based self-sampling and testing for sexually transmitted infections in Gugulethu, South Africa: Randomised controlled trial. Sex Transm Infect 2007; 83:552-557.
9. Keane FE, Bendall R, Saulsbury N, et al. A comparison of selftaken vulvovaginal and cervical samples for the diagnosis of Chlamydia trachomatis infection by polymerase chain reaction. Int J STD AIDS 2007; 18:98-100.
10. Masek BJ, Arora N, Quinn N, et al. Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program. J Clin Microbiol 2009; 47:1663-1667.
11. Chernesky MA, Martin DH, Hook EW, et al. Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs. J Clin Microbiol 2005; 43:127-131.
12. Skidmore S, Horner P, Herring A, et al. Vulvovaginal-swab or firstcatch urine specimen to detect Chlamydia trachomatis in women in a community setting? J Clin Microbiol 2006; 44:4389-4394.
13. Van Der Pol B, Liesenfeld O, Williams J, et al. Performance of the Cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2012; 50:2244-2249.
14. Taylor SN, Liesenfeld O, Lillis RA, et al. Evaluation of the Roche Cobas CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine. Sex Transm Dis 2012; 39: 543-549.
15. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005; 32:725-728.
16. Chernesky MA, Hook EW III, Martin DH, et al.Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sex Transm Dis 2005; 32:729-733.
17. Hoebe CJ, Rademaker CW, Brouwers EE, et al. Acceptability of self-taken vaginal swabs and first-catch urine samples for the diagnosis of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae with an amplified DNA assay in young women attending a public health sexually transmitted disease clinic. Sex Transm Dis 2006; 33:491-495.
18. Rose SB, Lawton BA, Bromhead C, et al. Self-obtained vaginal swabs for PCR Chlamydia testing: A practical alternative. Aust N Z J Obstet Gynaecol 2007; 47:415-418.